195 related articles for article (PubMed ID: 4063989)
41. Synthesis and tumor-initiating activities of dimethylchrysenes.
Amin S; Balanikas G; Huie K; Hecht SS
Chem Res Toxicol; 1988; 1(6):349-55. PubMed ID: 2979752
[TBL] [Abstract][Full Text] [Related]
42. Differences in conformations of covalent adducts derived from the binding of 5- and 6-methylchrysene diol epoxide stereoisomers to DNA.
Geacintov NE; Lee MS; Ibanez V; Amin S; Hecht SS
Carcinogenesis; 1990 Jun; 11(6):985-9. PubMed ID: 2347073
[TBL] [Abstract][Full Text] [Related]
43. Quantum chemical studies of methyl and fluoro analogs of chrysene: metabolic activation and correlation with carcinogenic activity.
Poulsen MT; Loew GH
Cancer Biochem Biophys; 1981; 5(2):81-90. PubMed ID: 7248920
[TBL] [Abstract][Full Text] [Related]
44. Identification of metabolites of 5,11-dimethylchrysene and 5,12-dimethylchrysene and the influence of a peri-methyl group on their formation.
Amin S; Camanzo J; Hecht SS
Carcinogenesis; 1982; 3(10):1159-63. PubMed ID: 7172414
[TBL] [Abstract][Full Text] [Related]
45. Metabolism of the carcinogen [3H]6-nitrochrysene in the preweanling mouse: identification of 6-aminochrysene-1,2-dihydrodiol as the probable proximate carcinogenic metabolite.
Delclos KB; el-Bayoumy K; Hecht SS; Walker RP; Kadlubar FF
Carcinogenesis; 1988 Oct; 9(10):1875-84. PubMed ID: 3168165
[TBL] [Abstract][Full Text] [Related]
46. Morphological transformation and DNA adduct formation by benz[j]aceanthrylene and its metabolites in C3H10T1/2CL8 cells: evidence for both cyclopenta-ring and bay-region metabolic activation pathways.
Nesnow S; Lasley J; Curti S; Ross J; Nelson G; Sangaiah R; Gold A
Cancer Res; 1991 Nov; 51(22):6163-9. PubMed ID: 1933875
[TBL] [Abstract][Full Text] [Related]
47. Stereoselective metabolism of chrysene by rat liver microsomes. Direct separation of diol enantiomers by chiral stationary phase h.p.l.c.
Weems HB; Fu PP; Yang SK
Carcinogenesis; 1986 Jul; 7(7):1221-30. PubMed ID: 3719913
[TBL] [Abstract][Full Text] [Related]
48. Two K-regions of 5-methylchrysene are sites of oxidative metabolism.
Bao Z; Yang SK
Biochem Biophys Res Commun; 1986 Dec; 141(2):734-40. PubMed ID: 3801024
[TBL] [Abstract][Full Text] [Related]
49. Mutagenicity and tumorigenicity of the four enantiopure bay-region 3,4-diol-1,2-epoxide isomers of dibenz[a,h]anthracene.
Chang RL; Wood AW; Huang MT; Xie JG; Cui XX; Reuhl KR; Boyd DR; Lin Y; Shih WJ; Balani SK; Yagi H; Jerina DM; Conney AH
Carcinogenesis; 2013 Sep; 34(9):2184-91. PubMed ID: 23671133
[TBL] [Abstract][Full Text] [Related]
50. Covalent DNA adducts formed in mouse epidermis by benzo[g]chrysene.
Giles AS; Seidel A; Phillips DH
Carcinogenesis; 1996 Jun; 17(6):1331-6. PubMed ID: 8681451
[TBL] [Abstract][Full Text] [Related]
51. Bay-region distortions in a methanol adduct of a bay-region diol epoxide of the carcinogen 5-methylchrysene.
Afshar CE; Carrell CJ; Carrell HL; Harvey RG; Kiselyov AS; Amin S; Glusker JP
Carcinogenesis; 1996 Nov; 17(11):2507-11. PubMed ID: 8968070
[TBL] [Abstract][Full Text] [Related]
52. Metabolism of the bay-region diol-epoxide of chrysene to a triol-epoxide and the enzyme-catalysed conjugation of these epoxides with glutathione.
Hodgson RM; Seidel A; Bochnitschek W; Glatt HR; Oesch F; Grover PL
Carcinogenesis; 1986 Dec; 7(12):2095-8. PubMed ID: 3779903
[TBL] [Abstract][Full Text] [Related]
53. Metabolic activation of 4H-cyclopenta[def]chrysene in human mammary carcinoma MCF-7 cell cultures.
Agarwal R; Coffing SL; Baird WM; Harvey RG; Dipple A
Chem Res Toxicol; 1999 May; 12(5):437-41. PubMed ID: 10328754
[TBL] [Abstract][Full Text] [Related]
54. Dimethylchrysene diol epoxides: mutagenicity in Salmonella typhimurium, tumorigenicity in newborn mice, and reactivity with deoxyadenosine in DNA.
Misra B; Amin S; Hecht SS
Chem Res Toxicol; 1992; 5(2):248-54. PubMed ID: 1643255
[TBL] [Abstract][Full Text] [Related]
55. Conformations of complexes derived from the interactions of two stereoisomeric bay-region 5-methylchrysene diol epoxides with DNA.
Kim MH; Roche CJ; Geacintov NE; Pope M; Pataki J; Harvey RG
J Biomol Struct Dyn; 1986 Apr; 3(5):949-65. PubMed ID: 3271420
[TBL] [Abstract][Full Text] [Related]
56. Convenient syntheses of dibenzo[c,p]chrysene and its possible proximate and ultimate carcinogens: in vitro metabolism and DNA adduction studies.
Sharma AK; Lin JM; Desai D; Amin S
J Org Chem; 2005 Jun; 70(13):4962-70. PubMed ID: 15960493
[TBL] [Abstract][Full Text] [Related]
57. Formation of DNA adducts in mouse skin treated with metabolites of chrysene.
Phillips DH; Hewer A; Grover PL
Cancer Lett; 1987 May; 35(2):207-14. PubMed ID: 3581051
[TBL] [Abstract][Full Text] [Related]
58. Peroxyl radical- and cytochrome P-450-dependent metabolic activation of (+)-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene in mouse skin in vitro and in vivo.
Pruess-Schwartz D; Nimesheim A; Marnett LJ
Cancer Res; 1989 Apr; 49(7):1732-7. PubMed ID: 2493985
[TBL] [Abstract][Full Text] [Related]
59. Further metabolism of diol-epoxides of chrysene and dibenz[a,c]anthracene to DNA binding species as evidenced by 32P-postlabelling analysis.
Hall M; Parker DK; Hewer AJ; Phillips DH; Grover PL
Carcinogenesis; 1988 May; 9(5):865-8. PubMed ID: 3365849
[TBL] [Abstract][Full Text] [Related]
60. Tumor-initiating activity of benz[c]acridine and twelve of its derivatives on mouse skin.
Levin W; Wood AW; Chang RL; Kumar S; Yagi H; Jerina DM; Lehr RE; Conney AH
Cancer Res; 1983 Oct; 43(10):4625-8. PubMed ID: 6883319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
